dr. jeffrey weber on ipilimumab for melanoma
Published 9 years ago • 285 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
2:05
dr. jeffrey weber explores nivolumab in advanced melanoma
-
2:18
dr. jeffrey weber on checkmate-064 trial for advanced melanoma
-
1:21
dr. jeffrey weber on potential breakthrough "cures" in melanoma
-
2:34
jeffrey weber, md, phd explains the importance of administering ipilimumab with a pd-l1 inhibitor
-
0:49
dr. weber on emerging therapies in melanoma
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
2:21
meet oncologist dr. jeffrey weber
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
1:22
dr. weber on nivolumab versus chemotherapy in advanced melanoma
-
2:05
dr. weber on adjuvant approaches in stage iii melanoma
-
2:53
dr. jeffrey weber discusses promising results of mrna-based melanoma vaccine trial
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:46
jeffrey weber, md, phd explains the importance of testing for nras as compared with a braf biomarker
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
1:14
dr. weber discusses advancements in melanoma
-
1:46
dr. weber on selecting immunotherapy for patients with melanoma